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ABSTRACT 
Background/Objectives: Excessive body mass index (BMI) has been linked to a low-grade 
chronic inflammation state. Unhealthy BMI has also been related to neuroanatomical changes 
in adults. Research in adolescents is relatively limited and has produced conflicting results. This 
study aims to address the relationship between BMI and adolescents’ brain structure as well as 
to test the role that inflammatory adipose-related agents might have over this putative link.  
Methods: We studied structural MRI and serum levels of interleukin-6, tumor necrosis factor 
alpha (TNF-α), C-reactive protein and fibrinogen in 65 adolescents (aged 12-21 years). 
Relationships between BMI, cortical thickness and surface area were tested with a vertex-wise 
analysis. Subsequently, we used backward multiple linear regression models to explore the 
influence of inflammatory parameters in each brain-altered area.  
Results: We found a negative association between cortical thickness and BMI in the left lateral 
occipital cortex (LOC) and the right precentral gyrus as well as a positive relationship between 
surface area and BMI in the left rostral middle frontal gyrus and the right superior frontal gyrus. 
In addition, we found that higher fibrinogen serum concentrations were related to thinning 
within the left LOC (β = -0.45, p < 0.001), while higher serum levels of TNF-α were associated to 
a greater surface area in the right superior frontal gyrus (β = 0.32, p = 0.045). Besides, we have 
also identified a trend that negatively correlates the cortical thickness of the left fusiform gyrus 
with the increases in BMI. It was also associated to fibrinogen (β = -0.33, p = 0.035). 
Conclusions: These results suggest that adolescents’ body mass increases are related with brain 
abnormalities in areas that could play a relevant role in some aspects of feeding behavior. 
Likewise, we have evidenced that these cortical changes were partially explained by 















Overweight and obesity have become a pandemic. Child and-youth obesity are rising at an 
alarming rate. According to the World Health Organization (WHO), over 340 million children and 
adolescents aged 5-19 were overweight or obese in 2016 [1]. This is a worldwide source of 
concern because excessive weight during youth has been associated with an increased incidence 
of cardiometabolic diseases (e.g., type II diabetes, stroke, and hypertension), some types of 
cancer, and premature mortality in adulthood [2].  
Excessive weight has been related to neuroanatomical changes in adults. Mainly, increases in 
body mass index (BMI) have been related to a wide-spread pattern of cortical gray matter 
volume (GMV) reductions [3]. In pediatric populations, although scarce, findings are in line with 
those described in adults, mostly in frontal and limbic regions [4, 5]. 
Despite cortical GMV has often been used to measure gray matter density of the cortical mantle, 
it is worth noting that cortical GMV can be regarded as the product of thickness and surface area 
[6, 7]. For this reason, analyzing cortical thickness and surface area separately could improve the 
specificity of the results, since a loss of GMV may reflect either reduced thickness, reduced area, 
or both [8]. Cortical thinning could provide some indication of neural loss, reduced size of neural 
cell bodies or degradation, and could be influenced by white matter properties, such as 
myelination [9]. On the other hand, surface area measures could mirror the tension or shrinkage 
of underlying white matter fibers [10]. In addition, these two constitutive components of cortical 
volume seem to be influenced by different genetic and cellular processes and follow distinct 
patterns of development [11]. Therefore, the study of cortical thickness and surface area 
separately can provide more accurate information about gray matter changes.  
To date, studies in adolescents assessing the relationship between cortical thickness and body 
weight are scarce and have produced conflicting results. While two studies showed a negative 
link between obesity and cortical thickness [12, 13], others found no relationship with obesity 
or BMI [14-17]. Notwithstanding, one of these works that did not identify any effect of BMI on 
healthy adolescents' cortical thickness observed a significant age-by-BMI z-score interaction 
related to altered cortical thickness across development [17]. Likewise, it is also worth pointing 
the recent study of Ronan and colleagues [18], since they found that increased BMI was 
associated with reduced cortical thickness in several regions of the prefrontal cortex in a sample 
of 2700 healthy children aged between 9 and 11. Regarding the association between BMI and 
surface area, only one study has examined it, which yielded null results [16].  
Excessive weight is related to a low-grade chronic inflammation state [19, 20] that might 
potentially lead to oxidative stress scenarios [21]. Both hypertrophied adipocytes and adipose 
tissue-resident macrophages produce inflammatory mediators such as interleukin-6 (IL-6), 
tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP) and fibrinogen [22-25]. Although 
a healthy brain is an immune-privileged organ due to the blood-brain barrier shielding properties 
[26], adipose-related inflammatory by-products can cross and disrupt its permeability, 
amplifying and sustaining a chronic inflammatory milieu [21, 27, 28]. 
There is evidence that points to a correlation between the levels of cytokines in blood and in the 
cerebrospinal fluid [29]. Elevated levels of peripheral pro-inflammatory agents could suggest a 
neuroinflammatory state, which in turn could be involved in potential cortical brain 
abnormalities BMI-related. In fact, one study with middle aged and elderly people reported that 
adiposity-related systemic inflammation may be related with brain structures [30]. 
As abovementioned, research exploring neuroanatomical correlates of BMI in adolescents is 
relatively limited, particularly in terms of cortical thickness and surface area. Our study has two 
aims: 1) to address the relationship between BMI and adolescents’ brain structure and 2) to test 
if this relationship could be explained by adipose-related levels of inflammatory biomarkers. We 
expect to find cortical changes related to an increase in BMI. Likewise, we assume that such 
connection will be partially explained by the presence of inflammatory agents.   
 
MATERIALS AND METHODS 
Participants 
This study includes 65 adolescents (age = 15.89 ± 2.72 years; 33 females), who were recruited 
from public primary care centers belonging to the Consorci Sanitari de Terrassa (Spain). All of 
them met two inclusion criteria: (1) being aged from 12 to 21 years old and (2) having a sex and 
age-specific BMI over the 5th percentile according to the 2000 Centers for Disease Control and 
Prevention (CDC) growth charts [31]. Volunteers older than 17 had to show a BMI higher than 
18.5 kg/m2. 
Individuals who met inclusion criteria and agreed to participate underwent a medical evaluation 
and a blood-sample, both performed in the Pediatric Endocrinology Unit at the Hospital de 
Terrassa in adolescents younger than 19 years old, and in the CAP Terrassa Nord for older 
participants. In this visit, participants’ clinical history was reviewed and anthropometric 
measures (i.e., weight and height) were taken to exclude those who presented (1) history of 
psychiatric illness (including eating disorders such as bulimia or binge eating disorder), (2) history 
of regular drug use (3) developmental, (4) neurological, or (5) systemic disorders (e.g., hyper or 
hypothyroidism and diabetes). Additionally, (6) meeting metabolic syndrome criteria [32] also 
was an exclusion criterion for participants older than 17 years old. The presence of metabolic 
syndrome in adolescents under 18 years of age was not taken into account because there is no 
general consensus to define pediatric metabolic syndrome [33].  
Participants who did not have any medical exclusion criteria went through a neuropsychological 
assessment to discard (7) the presence of global cognitive impairment (scalar score lower than 
7 in vocabulary subtests of Wechsler batteries [34, 35] was interpreted as an estimated IQ below 
85). Finally, adolescents who did not present any of the exclusion criteria abovementioned were 
proposed to undergo a magnetic resonance imaging (MRI). For this work, only those who 
accepted undertake this procedure were included in the study. 
The final sample was composed by 65 adolescents. The flow of included and excluded 
participants is detailed in depth in Supplementary Material section (Appendix A.1). An overview 
of demographic, anthropometric and inflammatory characteristics is shown in Table 1.  
This study was approved by the Institutional Ethics Committee of the University of Barcelona 
(CBUB); Institutional Review Board (IRB 00003099, assurance number: FWA00004225; http:// 
www.ub.edu/recerca/comissiobioetica.htm). The research was conducted in accordance with 
the Helsinki Declaration. Written informed consent was obtained from each participant (if older 
than 18 years old) or their parents prior to taking part in the study and after explaining the 
research purpose and procedures. 
 
Image acquisition 
Sixty-five adolescents underwent an MRI acquisition on a 3T MAGNETON Trio (Siemens, 
Germany) at the Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) from the 
Centre de Diagnòstic per la Image Clínic (CDIC). We acquired a high resolution T1-weighted 3D 
using a Magnetization Prepared Rapid Acquisition Gradient echo (MPRAGE) sequence with the 
following parameters: repetition time 2300ms; echo time 2.98ms; inversion time 900ms. A total 
of 240 contiguous 1-mm slices were acquired using a 256 x 256 matrix with an in-plane 




We performed the preprocessing and analysis of cortical thickness and surface area using 
standard procedures in FreeSurfer software (Version 6.0) (https://surfer.nmr.mgh.harvard.edu). 
Briefly, this process included motion correction and T1 averaging [36], removal of non-brain 
tissue [37], intensity normalization [38], cortical parcellation [39] and tessellation of gray/white 
matter tissue. Cortical thickness is represented by the distance between gray/white boundary 
and the gray/cerebrospinal fluid boundary at each vertex on the surface [40]. After Freesurfer 
preprocessing, results for each subject were visually inspected to ensure accuracy of 
registration, skull stripping, segmentation, and cortical surface reconstruction. Small 
imprecisions were detected across all participants. Consequently, errors were fixed by manual 




Blood samples were obtained from each participant after overnight fasting state to obtain serum 
levels of pro-inflammatory biomarkers (TNF-α, IL-6, high-sensitivity C-reactive protein (hs-CRP) 
and fibrinogen). This procedure was performed between 8:00 and 8:30 AM in the Pediatric 
Endocrinology Unit at the Hospital de Terrassa in participants younger than 19 and in the CAP 
Terrassa Nord for older volunteers. Blood samples were preserved at -80°C at the Logistics Park 
of Health (CatLab) until analyzed. Serum concentrations of hs-CRP and fibrinogen were 
determined in CatLab through nephelometry (Beckman Coulter Immage 800) and PT-derived 
fibrinogen (FIBPT) assay, respectively. Howbeit, fibrinogen levels of 29 adolescents were 
measured with STA-Neoplastin-Plus reactive (STA-Rack) while for the rest of participants was 
used Recombiplastin 2G reactive (ACLTOP 700). The inter-assay coefficient of variability for STA-
Rack was 6.52% while for ACLTOP 700 was 3.18%. The intra-assay coefficient of variability for 
ACLTOP 700 was 0.75%. Unfortunately, we cannot provide the coefficient of variability intra-
assay of STA-Rack because the register of its quality control is currently missing. TNF-α and IL-6 
concentrations were determined at the Research Center on Metabolism (Universitat de 
Barcelona). TNF-α was measured using a Quantikine HS ELISA Human TNF-α (R&D Systems, Ref. 
HSTA00E Lot P174731) and IL-6 were determined by Quantikine HS ELISA Human IL-6 (R&D 
Systems, Ref. HS600C Lot P178994). All these immunoassays were performed according to the 
manufacturer’s instructions.  
 
BMI calculations 
BMI, which results from dividing the weight in kilograms (kg) by the square of height in meters 
(m2), is the most common anthropometric measure used to determine obesity in adults [1]. 
Likewise, in pediatric population, the BMI is also used as a measure of adiposity since it is 
strongly correlated with body fat mass [41].  
Healthy BMI range in childhood varies considerably with age. Hence, in order to achieve a 
comparable measurement of BMI among participants in our sample, we transformed BMI into 
BMI z-score (BMIz) using the 2000 CDC growth charts [31]. These guidelines allow the obtention 
of age and sex-specific BMI percentiles and BMIz. Although both are equivalent, we decided to 
use BMIz because it is more suitable for statistical analysis [42]. For the 21-year-old participants, 
their BMI was calculated as if they were 20.  
 
Statistical analyzes 
Brain structure was assessed using two measures: cortical thickness and surface area. First, we 
explored the relationship between BMI, cortical thickness and surface area in a vertex-by-vertex 
fashion through Query Design Estimate Contrast (Qdec) interface of FreeSurfer. Age, gender 
(discrete variable) and years of education were set as nuisance factors in all image analysis to 
avoid its potential biasing effects over brain structure. In addition, total surface area was also 
controlled in surface area analysis. Analyzes were performed separately for each hemisphere 
with a 10 mm full-width at half maximum kernel. Results were corrected for multiple 
comparisons using a Monte-Carlo null-Z simulation (10,000 repetitions). Statistical significance 
was set at a cluster-wise corrected p-value (CWP) < 0.0125 (0.05/4) after considering the analysis 
of both cortical metrics (i.e., thickness and surface area) over the two hemispheres. Significant 
clusters were reported according to the Desikan’s atlas [39] in MNI305 space.  
Second, we performed Spearman correlations between BMIz and the serum levels of each 
inflammatory agent obtained (i.e., IL-6, TNF-α, CRP and fibrinogen) to ensure that these 
biomarkers were related with BMI in our sample. 
Next, we addressed the putative link between inflammatory agents and the resulting 
neuroanatomical alterations originally linked to an increase in BMI. For this, cortical thickness 
and surface area values from significant and trending clusters were extracted for further post-
hoc analyzes in IBM SPSS Statistics (version 23). We used backward multiple linear regression 
models to explore the influence of all inflammatory parameters with each significant cluster. 
Here we used standardized residuals to control for the nuisance factors included in our previous 
vertex-wise analyzes. The significance threshold was set at Bonferroni-adjusted p-value < 0.05. 
We also examined critical parameters of regression analysis to assure assumption fulfillment 




There was a negative relationship between cortical thickness (mm) and BMIz in the left lateral 
occipital cortex (LOC) and the right precentral gyrus. Moreover, we have also identified a trend 
that negatively correlates the cortical thickness of the left fusiform gyrus with the increases in 
BMIz. Regarding surface area (mm2), we found a positive relationship with BMIz in the left rostral 
middle frontal gyrus and the right superior frontal gyrus (Table 2; Figure 1-2). To assure the 
robustness and reliability of the results, we repeated the analyzes excluding the six 21-year-old 
participants. See Supplementary Material section (Appendix A.3). 
 
Correlation analyzes between BMIz and inflammatory biomarkers  
Spearman correlations reveled that BMIz was positively related with serum levels of hs-CRP (rs= 
0.568, p < 0.001), IL-6 (rs= 0.559, p < 0.001), TNF-α (rs= 0.320, p = 0.009) and fibrinogen (rs= 0.514, 
p < 0.001). All of them survived Bonferroni adjustment. See Supplementary Material section 
(Appendix A.4). Correlations between inflammatory biomarkers are also included in 
Supplementary Material section (Appendix A.5). 
 
Post-hoc regression models of inflammation biomarkers 
Post-hoc regression analyzes showed that cortical thickness from significant and trending 
clusters associated with higher BMIz were partially explained by the increase in serum levels of 
fibrinogen in the left LOC (R2 = 0.19, β = -0.45, p < 0.001) and the left fusiform gyrus (R2 = 0.09, 
β = -0.33, p = 0.035). Contrarily, the right precentral gyrus thickness did not exhibit a significant 
relationship with fibrinogen values (β = -0.24, p = 0.057). Likewise, the mean surface within the 
right superior frontal gyrus were explained to some degree through serum levels of TNF-α (R2 = 
0.09, β = 0.32, p = 0.045). In addition, although blood hs-CRP concentrations also partly 
explained surface increases in the left rostral middle frontal gyrus (R2 = 0.06, β = 0.28, p = 0.024), 
it did not pass the Bonferroni adjustment (β = 0.28, p = 0.12). Backward regression models are 
presented in detail in Supplementary Material section (Appendix A.6). Best-fitting significant 
uncorrected regression models with adjusted p-value are shown in Table 3. Figure 3 shows the 




This study aimed to assess the correlation between BMI and neuroanatomical changes in 
adolescents as well as the role that inflammatory agents might have over this relationship. We 
decided to use BMI instead of waist circumference or the waist-to-height ratio because BMI can 
be easily transformed into an age and sex-specific measure according to population rates (i.e., 
BMI z-score). None of the teenagers included in the study had any obesity-related comorbidity. 
This rigorous selection of participants was carried out with the aim of trying to isolate as best as 
possible the effect of BMI on brain structure, avoiding the potential confounding effects from 
other clinical comorbidities associated with unhealthy excess weight (e.g., insulin resistance, 
type 2 diabetes). 
 
Associations between cortical gray matter and BMI 
Using a vertex-wise approach, we found cortical thickness reductions associated with an 
increase in the BMIz in the left LOC, extending to the inferior parietal cortex and the right 
precentral gyrus, including the caudal middle frontal gyrus. In addition to that, we also found a 
trend that negatively correlates the cortical thickness of the left fusiform gyrus with the 
increases in BMIz. Our results are highly consistent with studies conducted in adults. Cortical 
thinning linked to BMI was also described in the left LOC [44], as well as in the left inferior 
parietal cortex, including LOC and fusiform areas, and the right precentral gyrus [45]. Both 
studies carried out vertex-wise correlations with a wide range of BMI that included healthy and 
unhealthy values that are compatible with obesity. 
However, our results are not in line with other work exploring cortical thickness changes related 
to BMI in teenagers. To date, two studies did not find an association between BMI and cortical 
thickness [15, 16]. The discrepancy between our results and these works could be explained by 
the age range of the sample, especially the upper age limit, because while both studies included 
adolescents not older than 18, we included participants in late adolescence. Moreover, this 
inconsistency also might account either because differences in the sample size or the software 
employed. 
Even though cortical areas in which we identified thickness changes related to weight increase 
have not been detected in adolescents so far, there is evidence to think that these brain regions 
could be altered in teenagers at an unhealthy weight situation, as they are involved in some 
aspects of feeding behavior. Both the LOC and the fusiform gyrus are two of the most reported 
areas in fMRI studies that investigate neural response to food stimuli [46]. Likewise, the LOC has 
also been linked to BMI in previous cortical thickness studies [44, 45], where it was typically 
related to visuospatial processing deficits in obesity. Additionally, in an electroencephalographic 
study, left LOC was pointed as one of several regions involved in salience tracking of high-energy 
and low-energy food and it was proposed to play a role in object recognition [47]. On the other 
hand, although precentral gyrus abnormalities are not too contrasted in unhealthy weight gain, 
this area has been described as a component of motor sensory networks implicated in visual 
recognition and control for food tasks [48]. 
Regarding surface area, we found a positive correlation with BMIz in two clusters with maximum 
peaks in the left rostral middle frontal gyrus, extending to the pars opercularis and the caudal 
middle frontal gyrus, and the right superior frontal gyrus, which included the caudal middle 
frontal, the rostral middle frontal and the precentral gyri. Both areas belong to the dorsolateral 
prefrontal cortex (DLPFC). As far as we know, only Saute and colleagues [16] examined the 
possible association between adolescents’ surface area and BMI. They did not find a relationship 
between surface area and BMI in 44 teenagers from 15 to 18.   
The DLPFC is among the latest brain regions to mature [49]. In typical development, the cortical 
area of the DLPFC shows age-related declines from 9 to 20 years old [50]. Accordingly, an 
increase in DLPFC surface area could be interpreted as an interference of the BMI-related 
inflammation with the prefrontal cortex synaptic pruning process. This mechanism could 
potentially reduce the effectiveness of frontal lobe functions in adolescence and later life. This 
speculation may be in line with the strong evidence that supports the existence of a negative 
relationship between executive functioning and unhealthy weight in teenagers [51, 52]. 
Nevertheless, smaller surface area in prefrontal regions has been associated with problems in 
executive functioning in adults [11]. Clearly, more studies are needed to validate these results.   
Another plausible explanation would be to consider that unhealthy BMI-increase may also be 
affecting underlying white matter, since tension-changes along the axons of white matter has 
been described as the primary driving force for cortical folding [53]. Likewise, a 
magnetoencephalographic study conducted in young females showed an increased resting-state 
functional connectivity in obese adolescents [54]. The authors pointed to the white matter 
expansion as a possible cause of this altered pattern of connectivity, suggesting that white 
matter expansion in obese people could be a reflection of abnormal lipid metabolism and 
increased accumulation of fat in central myelin throughout the brain. Therefore, changes in the 
DLPFC area could also be an indirect consequence of possible white matter alterations. 
 
Cortical gray matter findings and proinflammatory agents 
Addressing another main objective, we found that the relationship between gray matter 
structure and BMI was partly explained by inflammatory agents. Higher fibrinogen serum 
concentrations were related to thinning within the left LOC and the left fusiform gyrus. 
Alternatively, higher serum levels of TNF-α were associated to a greater surface area in the right 
superior frontal gyrus. 
Although the relationship between obesity and low-grade chronic inflammation is well known, 
our results suggest that peripheral inflammatory-related agents are associated with brain 
structure. Several studies have reported a significant correlation between the levels of cytokines 
in blood and in the cerebrospinal fluid [29]. Thus, it could be possible that elevated serum levels 
of inflammatory biomarkers might be reflecting the existence of a neuroinflammatory state, 
which in turn would be involved in the cortical brain alterations that we have identified. The 
reason why fibrinogen and TNF-α are related to opposite patterns (i.e., decrease and increase) 
and different metrics (i.e., thickness and surface) remains unclear. Two hypothetical 
explanations could be that (1) the course of the neuroinflammatory response may be 
disharmonious among different brain regions, and (2) the effect of neuroinflammation could be 
subjected to the specific developmental stage of each cortical region.    
Recent revisions show evidence that diet-induced obesity compromises the integrity of blood-
brain barrier (BBB) through endothelial dysfunction [19, 55, 56]. Although the most reported 
evidence is based in animal models of obesity, Gustafson et al. (2007) suggested that BBB 
permeability is also higher in overweight or obese people than controls [56]. Reduction in 
cortical thickness has been interpreted as a proxy of atrophy [57], as it might mirror neuronal 
loss, reduced size of neural cell bodies or degradation [10]. The brain regions we have described 
as thinner in relation to the BMI increase were those exhibiting a link with fibrinogen. Under 
normal circumstances, serum fibrinogen cannot penetrate into the central nervous system (CNS) 
due to the BBB. However, when the BBB is disrupted fibrinogen could leak from blood vessels 
and deposit in the CNS [58]. Although we have no evidence of the presence of fibrinogen in the 
CNS of our participants, the fact that fibrinogen was the serum inflammatory agent more 
associated with cortical thickness reductions could point towards that the inflammatory 
response might be at a more advanced stage. Likewise, other studies have demonstrated that 
fibrinogen is related with both neural death and synaptic degradation [59] as well as with 
reductions in neural density [60]; findings that could fit with a reduction in cortical thickness. 
Conversely, the fact that the changes related to BMI in the area of DLPFC were related to TNF-α 
but not to fibrinogen could mean that the neuroinflammatory response within DLPFC might be 
at an earlier stage, still incapable of causing a decrease in gray matter. However, after some 
time, the course of this response would continue advancing and would be able to produce gray 
matter decreases. This idea would be congruent with results reported by Cazettes and 
colleagues [30], since they found that the lateral orbitofrontal cortex volumes of 
overweight/obese adults were negatively associated with fibrinogen.  
As above mentioned, all regions of the brain do not end their development at the same time, 
being the prefrontal cortex the last brain region to reach adult maturity [49]. Hence, it might be 
possible that potential neuroinflammation response related to BMI could exercise different 
effects in different cortical regions as well as make different brain regions more susceptible to 
certain inflammatory biomarkers depending on the specific moment of development they are 
going through. Finally, it is worth considering that both possible interpretations (i.e., the 
desynchronized course of the neuroinflammatory response and the specific developmental 
stage of each brain region) might be complementary rather than exclusive. 
However, it is necessary to highlight again that these are only hypothetical explanations. On one 
side, there is no evidence that the permeability of BBB is disrupted in our sample. Moreover, it 
is worth noting that we only measured proinflammatory agents in serum. 
 
LIMITATIONS AND FUTURE DIRECTIONS 
This study has some limitations that should be acknowledged. Parametric cluster-wise Monte-
Carlo null-Z simulation analyzes could potentially overestimate some of our results. For this 
reason, we additionally performed a strict permutation testing approach. While this additional 
analysis showed similar results in cortical thickness, results in surface area did not reach 
significance.  While it is true that our sample size could have not enough statistical power to 
detect subtle cortical differences across healthy adolescents who only differ in BMI in 
permutation testing, there is not a validated method to calculate sample size in structural MRI 
studies. In addition, there are also methodological limitations that are worth to be pointed. The 
2000 CDC growth charts [31] only allow to calculate BMIz for individuals up to 20 years. Our 
study, however, included six 21-year-old participants to cover the entire period of adolescence. 
For this reason, we repeated the analyzes excluding the six 21-year-old participants, finding 
similar relationships between BMI, cortical thickness and area, albeit, as predictably, with a 
decreased corrected p-value (Appendix A.3). Besides that, despite some evidence towards a 
correlation between the levels of cytokines in the blood and in the cerebrospinal fluid [29], any 
interpretation about the concentration of fibrinogen and cytokines in the CNS is utterly 
speculative. Hence, although we found an association between systemic inflammation obesity-
related and brain structure, we cannot conclude that obesity is linked to a neuroinflammation 
state that alters the cortical mantle. Finally, the cross-sectional design of this study 
unfortunately does not allow us to conclude on causality. Therefore, as it is premature to draw 
firm conclusions, future research should continue the study of the possible relationship between 
cortical changes associated to BMI and inflammatory agents in larger samples. The confirmation 
of this association could help in the development of targeted interventions aimed at reducing 
peripheral obesity-related inflammation as well as its possible impact on the neuroinflammatory 
state and its harmful effects on the brain. 
 
CONCLUSIONS  
We have found a relationship between BMI and brain structure in adolescents. Specifically, we 
have detected that body mass increases were associated with thinner cortices in the left LOC 
and the right precentral gyrus as well as with greater surface area in the left rostral middle 
frontal gyrus and the right superior frontal gyrus. Likewise, we have also identified a trend 
between thickness decreases in the left fusiform gyrus and body mass increases. All these areas 
could play a relevant role in some aspects of feeding behavior. Moreover, we have evidenced 
that these cortical changes were partially associated with peripheral inflammatory agents such 
as fibrinogen and TNF-α.  
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Demographic, anthropometric and inflammatory characteristics. 
BMIz = body mass index z-score; HW = healthy weight; OW = overweight; O = obese; F = female; 
M = male; IQ estimation = Intelligence Quotient estimation; hs-CRP = high-sensitivity C-reactive 
protein; mg/dL = milligrams per deciliter; TNF-α = tumor necrosis factor alpha; pg/mL = 
picograms per milliliter; IL-6 = Interleukin-6; g/L = grams per liter. 
a Serum levels of fibrinogen considering all participants and both assay types (i.e., STA-Rack and 










 Mean SD Range 
Age (years) 15.89 2.72 12–21 
BMIz 1.07 1.06 -1.28–2.69 
Gender (F/M) 33/32  
Weight status (HW/OW/O) 28/10/27  
Years education 9.74 2.38 6–16 
IQ estimation (scalar score) 11.17 2.22 7–17 
hs-CRP (mg/dL) 3.45 9.11 0.12–67.80 
TNF-α (pg/mL) 0.89 0.35 0.26–1.95 
IL-6 (pg/mL) 2.41 3.11 0.38–18.76 
Fibrinogena (g/L) 3.67 0.81 2.23–6.04 
Fibrinogen STA-Rack (g/L) 3.67 0.66 2.60–5.33 
Fibrinogen ACLTOP 700 (g/L) 3.67 0.91 2.23–6.04 
Peak location Cluster size 
(mm2) 
Peak MNI coordinates Statistical 
(Z) 
Corrected             
p-value  X Y Z 
Thickness       
L–LOC 958.80 -41.6 -78.8 -2.5 -2.756 0.0092 
L–Fusiform 885.96 -32.9 -38.3 -17.8 -3.166 0.0177 
R–Precentral 1748.90 22.7 -19.0 55.2 -3.507 0.0001 
Surface area       
L–Rostral middle frontal 2528.97 -34.9 29.5 31.7 3.29 0.0014 


































Figure 1. Lateral and inferior views of the thickness reduction in relation to BMIz after adjusting 
for age, gender and years of education. Significant clusters in the left LOC and the right 
precentral gyrus and trending cluster in the left fusiform gyrus (a). Lateral and superior views of 
increasing surface area in relation to the BMIz after adjusting for age, gender, years of education 
and total surface area. Significant clusters in the left rostral middle frontal gyrus and the right 














Figure 2. Scatter plots showing association 
between BMIz and standardized residuals 
of cortical thickness in the left LOC (a) the 
left fusiform (b) and the right precentral (c) 
gyri; BMIz and standardized residuals of 
surface area in the left rostral middle 








z = 3.29; p = 0.0014; n = 65 
z = -3.166; p = 0.0177; n = 
65 z = 2.646; p = 0.0008; n = 65 
z = -3.507; p = 0.0001; n = 65 
z = -2.756; p = 0.0092; n = 65 
 
Table 3. 
Best-fitting significant uncorrected regression models with adjusted p-value. 
+ Adjusted R squared value; SE = standard error; L = left; R = right; LOC = lateral occipital cortex; 
Ros = rostral; mid = middle; TNF-α = tumor necrosis factor alpha; hs-CRP = high-sensitivity C-





 Biomarker +R2 β t SE p 
Bonferroni 
adjusted        
p-value 
Thickness        
L–LOC Fibrinogen 0.19 -0.45 -3.99 0.14 < 0.001*** < 0.001*** 
L–Fusiform Fibrinogen 0.09 -0.33 -2.77 0.14 0.007** 0.035* 
Surface area        
L–Ros mid frontal hs-CRP 0.06 0.28 2.31 0.01 0.024* 0.12 
R–Superior frontal TNF-α 0.09 0.32 2.70 0.33 0.009** 0.045* 
    L–Fusiform: β = -0.33; p = 0.035 




n = 65 
 
Figure 3. Scatter plots showing the association between standardized residuals of cortical 
thickness and blood fibrinogen concentration (a) and the link between standardized residuals 
of surface area and serum levels of TNF-α (b).  
SUPPLEMENTARY MATERIAL  
 









Appendix A.2 – Examined standardized residuals in regression models of inflammation biomarkers 







 Appendix A.3 – Vertex-wise results excluding the six 21-year-old participants. 















OI064 -2.21561 .05003 .00421 .26928 .89240 
OI017 -2.17765 .03896 .00053 .03382 .89485 
CI055 2.08438 .06948 .01470 .94106 .91855 
CI065 2.05370 .03808 .00205 .13110 .91252 
L-Fusiform thickness 
OI045 -2.07634 .04274 .00369 .23635 .91086 
SI032 2.03314 .03901 .00281 .17987 .91579 
R-Superior frontal area  
CI068 -2.00486 .03502 .00146 .09347 .91833 
OI067 3.20944 .10903 .00493 .31579 .73150 
OI049 2.88932 .07617 .00223 .14255 .78661 
Peak location Cluster size 
(mm2) 
Peak MNI coordinates Statistical 
(Z) 
Corrected 
p-value  X Y Z 
Thickness       
L–LOC 822.39 -43.3 -69.0 -2.0 -2.536    0.0287   
L–Fusiform 778.57 -32.3 -38.7 -17.5 -3.135   0.0386 
R–Precentral 1319.42 23.4 -18.7 55.3 -3.103     0.0018   
Surface area       
L–Rostral middle frontal                   2743.18 -35.5 29.2 31.4 3.129   0.0005 
L–Superior frontal 1631.18     -13.2 32.8 18.2 2.947    0.0446   
R–Superior frontal 3713.02       7.1 33.1 43.8 2.926 0.0001 



















hs-CRP = high-sensitivity C-reactive protein; IL-6 = Interleukin-6; TNF-α = tumor necrosis factor 

















Rho de Spearman  
 BMIz 
hs-CRP               Correlation coefficient           
                            Sig (bilateral) 
0.568 
< 0.001*** 
IL-6                     Correlation coefficient           
                            Sig (bilateral) 
0.559 
< 0.001*** 
TNF-α                 Correlation coefficient           
                            Sig (bilateral) 
0.320 
0.009** 
Fibrinogen         Correlation coefficient           
                            Sig (bilateral) 
0.514 
< 0.001*** 
Bonferroni adjusted p-value   
 BMIz 
hs-CRP               Correlation coefficient           
                            Sig (bilateral) 
0.568 
< 0.001*** 
IL-6                     Correlation coefficient           
                            Sig (bilateral) 
0.559 
< 0.001*** 
TNF-α                 Correlation coefficient           
                            Sig (bilateral) 
0.320 
0.036* 
Fibrinogen         Correlation coefficient           




Correlation matrix between inflammatory biomarkers. 
  hs-CRP IL-6 TNF-α Fibrinogen 
hs-CRP Correlation coefficient 1 .564** .150 .589** 
 Sig. (bilateral)  .000 .232 .000 
IL-6 Correlation coefficient .564** 1 .126 .488** 
 Sig. (bilateral) .000  .318 .000 
TNF-α Correlation coefficient .150 .126 1 .260* 
 Sig. (bilateral) .232 .318  .037 
Fibrinogen Correlation coefficient .589** .488** .260* 1 
 Sig. (bilateral) .000 .000 .037  
hs-CRP = high-sensitivity C-reactive protein; IL-6 = Interleukin-6; TNF-α = tumor necrosis factor 




















Appendix A.6 – Backward multiple linear regression models exploring the influence of all 
inflammatory parameters with each significant cluster linked to an increase in BMI. 
 
Table A.6.1 
Backward regression models examining the link between the left LOC thickness and 
inflammation biomarkers. 
LOC = lateral occipital cortex; SE = standard error; +Adjusted R squared value; hs-CRP = high-
sensitivity C-reactive protein; IL-6 = Interleukin-6; TNF-α = tumor necrosis factor alpha; ** p < 




Backward regression models examining the link between the left fusiform thickness and 
inflammation biomarkers. 
SE = standard error; +Adjusted R squared value; hs-CRP = high-sensitivity C-reactive protein;         
IL-6 = Interleukin-6; TNF-α = tumor necrosis factor alpha; ** p < 0.01.   
 
 
Model β t SE p   +R2 
Sig. F 
Change 
1       hs-CRP 0.19 1.23 0.02 0.222 
0.18 0.003 
         IL-6 -0.06 -0.40 0.04 0.693 
         TNF-α   -0.12 -1.00 0.33 0.323 
         Fibrinogen -0.50 -3.41 0.18 0.001** 
2       hs-CRP 0.16 1.18 0.02 0.242 
0.19 0.693          TNF-α   -0.12 -1.00 0.32 0.319 
         Fibrinogen -0.52 -3.62 0.17 0.001** 
3       hs-CRP 0.16 1.18 0.02 0.241 
0.19 0.319 
         Fibrinogen -0.55 -3.93 0.17 < 0.001*** 
4       Fibrinogen  -0.45 -3.99 0.14 < 0.001*** 0.19 0.241 
Model β t SE p   +R2 
Sig. F 
Change 
1       hs-CRP -0.10 -0.59 0.02 0.559 
0.06 0.115 
         IL-6 0.06 0.42 0.05 0.675 
         TNF-α   -0.02 -0.18 0.35 0.855 
         Fibrinogen -0.30 -1.89 0.19 0.064 
2       hs-CRP -0.10 -0.59 0.02 0.556 
0.07 0.855          IL-6 0.06 0.43 0.05 0.673 
         Fibrinogen -0.30 -1.98 0.19 0.052 
3       hs-CRP -0.07 -0.47 0.02 0.644 
0.08 0.673 
         Fibrinogen -0.29 -1.95 0.18 0.056 
4       Fibrinogen  -0.33 -2.77 0.14 0.007** 0.09 0.644 
Table A.6.3 
Backward regression models examining the link between the right precentral thickness and 
inflammation biomarkers. 
SE = standard error; +Adjusted R squared value; hs-CRP = high-sensitivity C-reactive protein;         
IL-6 = Interleukin-6; TNF-α = tumor necrosis factor alpha; 






Linear regression models examining the association between the left rostral middle frontal 
surface area and inflammation biomarkers. 
SE = standard error; +Adjusted R squared value; hs-CRP = high-sensitivity C-reactive protein;         
IL-6 = Interleukin-6; TNF-α = tumor necrosis factor alpha; * p < 0.05. 
 
 
Model β t SE P   +R2 
Sig. F 
Change 
1       hs-CRP 0.09 0.53 0.02 0.600 
-0.002 0.428 
         IL-6 -0.05 -0.33 0.05 0.740 
         TNF-α   0.01 0.08 0.36 0.935 
         Fibrinogen -0.27 -1.64 0.20 0.106 
2       hs-CRP 0.09 0.53 0.02 0.597 
0.02 0.935          IL-6 -0.05 -0.34 0.05 0.738 
         Fibrinogen -0.26 -1.67 0.19 0.100 
3       hs-CRP 0.07 0.44 0.02 0.664 
0.03 0.738 
         Fibrinogen -0.28 -1.82 0.19 0.074 a 
4       Fibrinogen  -0.24 -1.94 0.15 0.057 a 0.04 0.664 
Model β t SE p   +R2 
Sig. F 
Change 
1       hs-CRP 0.27 1.65 0.02 0.104 
0.04 0.175 
         IL-6 -0.13 -0.87 0.05 0.387 
         TNF-α   0.04 0.28 0.35 0.780 
         Fibrinogen 0.13 0.83 0.19 0.412 
2       hs-CRP 0.27 1.66 0.02 0.102 
0.05 0.780          IL-6 -0.13 -0.88 0.05 0.383 
         Fibrinogen   0.14 0.91 0.19 0.365 
3       hs-CRP 0.22 1.44 0.02 0.156 
0.06 0.383 
         Fibrinogen   0.12 0.73 0.18 0.469 
4       hs-CRP 0.28 2.31 0.01 0.024* 0.06 0.469 
Table A.6.5 
Linear regression models examining the link between the right superior frontal surface area and 
inflammation biomarkers. 
SE = standard error; +Adjusted R squared value; hs-CRP = high-sensitivity C-reactive protein;         
IL-6 = Interleukin-6; TNF-α = tumor necrosis factor alpha; * p < 0.05; ** p < 0.01.  
 
Model β t SE p   +R2 
Sig. F 
Change 
1       hs-CRP 0.09 0.54 0.02 0.593 
0.06 0.107 
         IL-6 -0.003 -0.02 0.05 0.984 
         TNF-α   0.30 2.36 0.35 0.021* 
         Fibrinogen 0.05 0.30 0.19 0.765 
2       hs-CRP 0.09 0.58 0.02 0.564 
0.07 0.984          TNF-α   0.30 2.38 0.34 0.020* 
         Fibrinogen 0.05 0.31 0.18 0.761 
3       hs-CRP 0.11 0.93 0.01 0.356 
0.09 0.761 
         TNF-α   0.31 2.52 0.33 0.014* 
4       TNF-α    0.32 2.70 0.33 0.009** 0.09 0.356 
